Additionally, Federico et al. reported that the presence of positive autoantibodies, including RF and ACPA, is associated with an elevated risk of future cardiovascular damage in patients with early-stage RA, within the first year of disease onset [89]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.